MASSACHUSETTS
BIOMEDICAL
INITIATIVES
MBI is the longest-running life sciences incubator in the Commonwealth. We help emerging life sciences companies advance from concept to clinical trials, create jobs, and promote economic development.
Incubate
We help emerging life sciences companies advance from concept to clinical trials so they can bring lifesaving products to patients
Companies
Since 2000, MBI has incubated over 188 companies that have created over 1,800 jobs and raised over $1.4 billion
Cluster Building
We support economic and workforce development to create a sustainable ecosystem in Massachusetts
Success Stories
TransCode Therapeutics
A platform delivery company focusing on oncology, TransCode launched clinical trials while at MBI. The team closed a $30M IPO event while at our incubator and announced an additional $7M IPO shortly after graduating in 2023.
iVexSol
iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.
Invetx
A veterinary therapeutics company focused on biopharmaceuticals that bring the best of human biotechnology to animal health, Invetx graduated from MBI in 2022 and has raised over $80M+.
featured news
Leal Therapeutics, an MBI startup raises $45M
Leal Therapeutics, a scaling MBI startup company, has just raised $45M for ALS and schizophrenia treatment
Here’s how MA plans to keep its edge in biotech
A growing effort is underway to establish Central Massachusetts as a global biomanufacturing hub. It has a more competitive cost of living than Greater Boston, more land available for the development of manufacturing plants, and a key advantage over southern states for biotech companies.